In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

With nearly 20 percent of U.S. adults affected by depression, the prevalence of this mental health condition drives many to explore relief from its most challenging symptoms. A recent study offers ...

When added to stable selective serotonin reuptake inhibitors (SSRI) treatment, transcranial direct current stimulation (tDCS) was not superior to sham stimulation for major depressive disorder (MDD), ...

While most tDCS devices have limitations in precise stimulation and show varying treatment effectiveness due to not considering individual brain structures, Neurophet has developed an AI-powered ...

Unsupervised, at-home use of transcranial direct current stimulation (tDCS) was no better than a sham control for treating a major depressive episode, a randomized trial showed. The PSYLECT trial of ...

Depression affects approximately 280 million people all over the world, and disproportionately affects the female population — it is 50% more common in women than men. Treatments range from ...

BOSTON, March 11, 2025 /PRNewswire/ -- Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials for life science pioneers, and Sooma Medical, a world-leading provider of ...

A noninvasive, home-based brain treatment with transcranial direct current stimulation (tDCS) can reduce pain severity, improve pain-related disability, and enhance endogenous pain modulation in women ...